The latest biotech news

News and Trends 7 Oct 2022

Scientists at IRB Barcelona and PCCB create study model for Ewing sarcoma

Ewing sarcoma is the second most frequent bone tumor in children, adolescents, and young adults. There is no specific treatment for this disease and current management is still limited to surgery, radiotherapy, and chemotherapy. The long-term survival of patients with metastatic or relapsed Ewing sarcoma is very low. Ewing sarcoma is caused by a single […]

October 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Oct 2022

Beyond Biotech podcast 17: BIO-Europe, National Hemophilia Foundation

This week, we have three interviews. Our guests are: Pam Putz, managing director of EBD Group EU; André Hofmann, CEO of biosaxony; and Kevin Mills, chief scientific officer at the National Hemophilia Foundation and Teri Willey, managing director of the National Hemophilia Foundation’s Pathway to Cures. We also have our weekly chat with global commercial […]

October 7, 2022

cancer cell screening drug discovery microplate

News and Trends 7 Oct 2022

GATC AI platform reduces time to find opioid use disorder candidates

GATC Health says the new drug candidates discovered by its proprietary AI drug discovery and prediction platform to treat opioid use disorder (OUD) and fentanyl addiction have entered pre-clinical development. GATC is partnering with Christie D. Fowler at the University of California, Irvine (UCI) and global scientific testing company, Eurofins Discovery, for the pre-clinical programs […]

October 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Oct 2022

Promising results for methamphetamine addiction treatment

Addiction Cure Therapeutic Sciences Inc., a biotech company targeting drug and alcohol addiction cures and treatments, has announced results from its epigenetic testing. Data from the mouse models in-lab testing indicates a lead HDAC (histone deacetylases) inhibitor can modulate the behavioral effects of methamphetamine, promoting sustained protection, despite repeated exposure to methamphetamine. If successful, this […]

October 7, 2022 - 2 minutesmins - By Jim Cornall

conveyor belt of medical vials for scale up production

News and Trends 7 Oct 2022

Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number

Mission Bio has announced the availability of the Tapestri VCN Assay, the first high-throughput commercial single-cell assay to simultaneously quantify vector copy number (VCN) and transduction at the level of individual cells. For the first time, developers of cell therapies like CAR-T cells will be able to apply multi-omic analysis to assess the cell-to-cell variability […]

October 7, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 7 Oct 2022

Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines

Ziphius Vaccines, a biopharmaceutical company developing vaccines and therapeutics based on self-amplifying RNA (saRNA), and UZ Ghent have entered a public-private collaboration for the scale up and manufacturing of prophylactic self-amplifying RNA vaccines based on GMP (good manufacturing practice) standards. The collaboration is a first in Europe where a university hospital produces GMP grade prophylactic […]

October 7, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

Growing hub Lithuania ready to welcome biotech sector to EFIB’22

On October 26 and 27 the Lithuanian capital, Vilnius, is hosting the European Forum for Industrial Biotechnology & the Bioeconomy 2022 (EFIB’22). EFIB, one of Europe’s top biotech events, will bring together business leaders, entrepreneurs, scientists, and investors. Executive director of the Lithuanian Biotechnology Association, Agnė Vaitkevičienė, explains the importance of EFIB and the potential […]

October 6, 2022 - 5 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

Catawba College and Eremid open genomics lab to offer undergrad training

Catawba College and Eremid Genomic Services, LLC, a genomics contract research provider, are opening the Bill and Shari Graham Genomics Laboratory specializing in genomic sequencing at Eremid’s facilities on the North Carolina Research Campus (NCRC) in Kannapolis, North Carolina. “The Graham Genomics Lab is an example of the exceptional liberal arts education offered at Catawba […]

October 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

Novartis Biome UK Heart Health Catalyst 2022 winners announced

Novartis Pharmaceuticals UK has announced that Xim, creators of Lifelight, and PocDoc are the successful companies of the Novartis Biome UK Heart Health Catalyst 2022, in partnership with Medtronic, RYSE Asset Management, Chelsea and Westminster Hospital NHS Foundation Trust and its official charity CW+. Lifelight and PocDoc will receive support to scale their innovative digital […]

October 6, 2022 - 2 minutesmins - By Jim Cornall

News and Trends 6 Oct 2022

New approaches beckon for small cell lung cancer treatment

Small cell lung cancer (SCLC) is a particularly aggressive tumor that has so far been treated with standardized measures. However, a study led by MedUni Vienna in Austria has shown for the first time that different SCLC subtypes have specific molecular characteristics, which is why those affected respond in different ways to cancer treatment. This […]

October 6, 2022 - 3 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

Big Idea Ventures announces cohort of 17 start-ups

Big Idea Ventures has revealed its latest accelerator cohort. Seventeen early-stage startups were selected for pre-seed investment as part of Big Idea Ventures’ bi-annual new protein accelerator program. Investments were made through the firm’s three offices in New York, Paris and Singapore and the firm’s first fund – New Protein Fund I ($50 million+). “The […]

October 5, 2022 - 7 minutesmins - By Jim Cornall

News and Trends 5 Oct 2022

FDA fast tracks Immutep non-small cell lung cancer candidate

Immutep Limited says the United States Food and Drug Administration (FDA) has granted fast track designation to eftilagimod alpha (efti or IMP321) in combination with pembrolizumab for the treatment of first line non-small cell lung cancer (NSCLC). Efti is the company’s first-in-class soluble LAG-3 clinical stage candidate, which activates antigen presenting cells (APC) to engage […]

October 5, 2022 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Scientists at IRB Barcelona and PCCB create study model for Ewing sarcoma

Beyond Biotech podcast 17: BIO-Europe, National Hemophilia Foundation

GATC AI platform reduces time to find opioid use disorder candidates

Promising results for methamphetamine addiction treatment

Mission Bio launches first commercial high-throughput cell therapy assay for measuring vector copy number

Ziphius and UZ Ghent collaborating on manufacture of saRNA-based vaccines

Growing hub Lithuania ready to welcome biotech sector to EFIB’22

Catawba College and Eremid open genomics lab to offer undergrad training

Novartis Biome UK Heart Health Catalyst 2022 winners announced

New approaches beckon for small cell lung cancer treatment

Big Idea Ventures announces cohort of 17 start-ups

FDA fast tracks Immutep non-small cell lung cancer candidate

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!